Burden of Premature Atrial Complexes and Risk of Recurrent Stroke and Death in Patients with Mild to Moderate

Michala Herskind Sejr1, Ole May1, Dorte Damgaard2

  • 1Cardiovascular Research Unit, Department of Cardiology, Regional Hospital West Jutland, Herning, Denmark.

Insights

High numbers of premature atrial complexes (PACs) and short atrial fibrillation (AF) runs did not increase stroke or death risk in patients recently experiencing ischemic stroke or transient ischemic attack (TIA). Further research is needed to understand PACs and AF

Area of Science:

  • Cardiology
  • Neurology
  • Clinical Electrophysiology

Background:

  • Premature atrial complexes (PACs) are increasingly recognized as a potential precursor to atrial fibrillation (AF).
  • Current guidelines do not recommend anticoagulation for patients with high PAC burden despite suspected stroke risk.
  • This study investigates the association between PACs, short AF runs, and adverse cardiovascular outcomes.

Purpose of the Study:

  • To determine if a high burden of PACs or brief AF episodes (under 30 seconds) predict recurrent ischemic stroke, transient ischemic attack (TIA), or death.
  • To analyze data from a large cohort of patients with acute ischemic stroke or TIA without prior AF diagnosis.
  • To assess the risk associated with these arrhythmias in a post-stroke/TIA population.

Main Methods:

  • A 48-hour continuous electrocardiogram (ECG) was performed within one week of ischemic stroke or TIA.
  • Premature atrial complexes (PACs) were quantified as the mean number per hour.
  • Cox Regression analysis was employed to calculate hazard ratios for adverse events, with follow-up data from national registries.

Main Results:

  • The study included 1507 patients (60% ischemic stroke, 40% TIA), with 98.7% experiencing mild to moderate events.
  • No significant association was found between PAC burden quartiles and the risk of recurrent stroke/TIA or death.
  • Nonsustained atrial fibrillation (AF) episodes lasting less than 30 seconds were also not linked to an increased risk of stroke/TIA or death.

Conclusions:

  • In patients with recent ischemic stroke or TIA, neither a high burden of PACs nor brief AF episodes (<30 seconds) were associated with an increased risk of recurrent stroke/TIA or death.
  • These findings suggest that current anticoagulation guidelines may not need revision based solely on PAC burden or short AF runs in this patient group.
  • Further investigation is warranted to fully elucidate the role of PACs and short AF runs in cardiovascular risk stratification.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
389
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
649
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
314
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.6K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
547